Member Exclusive NEWS ROUND-UP

Cell therapy weekly: Roche acquires MS program and GvHD therapy receives Orphan Drug Designation

This week: Cynata's CYP-001 receives Orphan Drug Designation and Phase III disc degeneration trial completes enrollment.

Go to the profile of RegMedNet
Apr 05, 2018
0
0

Please sign in or register for FREE

No comments yet.